Lactate: A Metabolic Driver in the Tumour Landscape.

mitochondria tumour metabolism tumour microenvironment tumour–stroma interplay

Journal

Trends in biochemical sciences
ISSN: 0968-0004
Titre abrégé: Trends Biochem Sci
Pays: England
ID NLM: 7610674

Informations de publication

Date de publication:
02 2019
Historique:
received: 02 08 2018
revised: 14 09 2018
accepted: 25 10 2018
pubmed: 27 11 2018
medline: 13 4 2019
entrez: 27 11 2018
Statut: ppublish

Résumé

The presence of lactate in human tumours has been long neglected, confined to the role of a waste product derived from glycolysis and as a biomarker of malignancy. More recently, lactate has been rediscovered as signalling molecule that plays important roles in the regulation of the metabolic pathways, the immune response, and cell-to-cell communication within the tumour microenvironment. This review examines recent discoveries about the functional role of lactate in shaping the behaviour and the phenotype of tumour and tumour-associated cells, and describes potential clinical approaches to target lactate transport and metabolism in tumours.

Identifiants

pubmed: 30473428
pii: S0968-0004(18)30227-5
doi: 10.1016/j.tibs.2018.10.011
pii:
doi:

Substances chimiques

Lactic Acid 33X04XA5AT

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

153-166

Informations de copyright

Copyright © 2018 Elsevier Ltd. All rights reserved.

Auteurs

Luigi Ippolito (L)

Department of Experimental and Clinical Biomedical Sciences, University of Florence, 50134 Florence, Italy.

Andrea Morandi (A)

Department of Experimental and Clinical Biomedical Sciences, University of Florence, 50134 Florence, Italy.

Elisa Giannoni (E)

Department of Experimental and Clinical Biomedical Sciences, University of Florence, 50134 Florence, Italy.

Paola Chiarugi (P)

Department of Experimental and Clinical Biomedical Sciences, University of Florence, 50134 Florence, Italy. Electronic address: paola.chiarugi@unifi.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH